Silvant Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,124
Closed -$1.65M 321
2025
Q4
$1.65M Hold
20,124
0.06% 141
2025
Q3
$1.51M Sell
20,124
-1,097
-5% -$81.8K 0.05% 144
2025
Q2
$1.57M Hold
21,221
0.06% 138
2025
Q1
$1.71M Hold
21,221
0.08% 131
2024
Q4
$1.66M Hold
21,221
0.07% 131
2024
Q3
$1.99M Sell
21,221
-2,668
-11% -$224K 0.09% 120
2024
Q2
$1.86M Hold
23,889
0.08% 125
2024
Q1
$2.17M Buy
23,889
+23,529
+6,536% +$1.96M 0.1% 115
2023
Q4
$27.8K Hold
360
﹤0.01% 279
2023
Q3
$24.5K Hold
360
﹤0.01% 284
2023
Q2
$29.2K Hold
360
﹤0.01% 280
2023
Q1
$29.5K Buy
+360
New +$25.7K ﹤0.01% 270

Other funds holding GEHC

Silvant Capital Management's GEHC Position: Q1 2026 in Review

Silvant Capital Management sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 20,124 shares — an estimated $1.65M sold.

Silvant Capital Management first reported a position in GEHC in Q1 2023 and held it in 12 quarters. The position peaked at $2.17M in Q1 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Silvant Capital Management reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Silvant Capital Management sold 20,124 GE HealthCare shares in Q1 2026, an estimated $1.65M.
  • Silvant Capital Management first reported a position in GE HealthCare in Q1 2023 and held it in 12 quarters.
  • Silvant Capital Management's GE HealthCare position peaked at $2.17M in Q1 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.